4-aminopyrimidine has been researched along with indazoles in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boehm, HJ; Boehringer, M; Bur, D; Gmuender, H; Huber, W; Klaus, W; Kostrewa, D; Kuehne, H; Luebbers, T; Meunier-Keller, N; Mueller, F | 1 |
Aoki, Y; Fukami, TA; Hasegawa, K; Kim, SJ; Miura, T; Na, YJ; Ono, N; Shimma, N; Shindo, H; Shiratori, Y; Suda, A; Tsukuda, T; Yoon, DO | 1 |
2 other study(ies) available for 4-aminopyrimidine and indazoles
Article | Year |
---|---|
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening.
Topics: Anti-Infective Agents; Coumarins; Crystallography, X-Ray; DNA Topoisomerases, Type II; Enzyme Inhibitors; Indazoles; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Novobiocin; Protein Binding; Structure-Activity Relationship; Surface Plasmon Resonance; Topoisomerase II Inhibitors; Ultracentrifugation | 2000 |
Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.
Topics: Adenosine Triphosphatases; Administration, Oral; Animals; Antineoplastic Agents; Benzopyrans; Computer Simulation; Dose-Response Relationship, Drug; Drug Design; Drug Discovery; Escherichia coli; HSP90 Heat-Shock Proteins; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Neoplasms; Reproducibility of Results; Structure-Activity Relationship; Surface Plasmon Resonance; Triazines; Xenograft Model Antitumor Assays | 2011 |